Cardiac pacing: How it started, where we are, where we are going

Heart Rhythm

Volumn 1, Issue 5 SUPPL., 2004, Pages C115-C126

  Hayes, David L ^b   Furman, Seymour ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADAMS STOKES ATTACK; ARTIFICIAL HEART PACEMAKER; AUTOMATION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEFIBRILLATION; DEFIBRILLATOR; DEVICE REMOVAL; ELECTRIC BATTERY; ELECTRONICS; EQUIPMENT DESIGN; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORBIDITY; MORTALITY; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PULSE GENERATOR; QUALITY OF LIFE; REVIEW; SAFETY; SYNCOPE; TELEMETRY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 14644421587     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2004.10.023     Document Type: Review

References (61)

1. Zoll PM. Resuscitation of the heart in ventricular standstill by external electric stimulation. N Engl J Med 1952; 247:768-771.
2. Zoll PM, Linenthal AJ, Norman LR, et al. Treatment of unexpected cardiac arrest by external electric stimulation of the heart. N Engl J Med 1956; 254:541-546.
3. Zoll PM, Linenthal AJ, Norman LR, Paul MH, Gibson W. Treatment of unexpected cardiac arrest by external electric stimulation of the heart. N Engl J Med 1956; 254:541-546.
4. Furman S. The early history of cardiac pacing. PACE 2003; 26:2023-2032.
5. Floresco N. Pince Excitatrice. J Physiol Path General 1905; 7:785-786.
6. Marmorstein M. Contribution a l'etude des excitation electriques localises sur le coeur en rapport avec la topographie de l'innervation du coeur chez le chien. [in French] J Physiol Path 1927;25:617-625.
7. Lidwill MC. Cardiac disease in relation to anaesthesia. Proceedings of the Third Session, Australasian Medical Congress (British Medical Association) Sydney, Australia, September 2-7, 1929. pp. 160.
8. Hyman AS. Resuscitation of the stopped heart by intracardial therapy. II Experimental use of an artificial pacemaker.Arch Intern Med 1932; 50:283-305.
9. Leatham A, Cook P, Davies JG. External electric stimulator for treatment of ventricular standstill. Lancet 1956; 2:1185-1189.
10. Glenn WWL, Mauro A, Longo E, et al. Remote stimulation of the heart by radio-frequency transmission. N Engl J Med 1959; 261:948-951.
11. Abrams LD, Hudson WA, Lightwood R. A surgical approach to the management of heart-block using an inductive coupled artificial cardiac pacemaker. Lancet 1960; 1:1372-1374.
12. Siddons AHM. Long-term artificial cardiac pacing: Experience in adults with heart block. Ann Roy Coll Surg Eng 1963; 32:22-41.
13. Chardack WM, Gage AA, Greatbatch W. A transistorized, self-contained implantable pacemaker for the long-term correction of complete heart block. Surgery 1960; 48:643-654.
14. Hunter SW, Roth NA. The platform bipolar myocardial electrode for prolonged treatment of total heart block. Lancet 1961; 81:115-117.
15. Zoll PM, Frank HA, Zarsky LR, et al. Long-term electrical stimulation of the heart for Stokes-Adams disease. Ann Surg 1961; 154:330-346.
16. Kantrowitz A, Cohen R, Raillard H, et al. The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynec Obstet 1962; 115:415-420.
17. Ruben S, inventor. US Patent 2,422,045. 1947.
18. Greatbatch W, Lee JH, Mathias W, et al. The solid-state lithium battery: A new improved chemical power source for implantable cardiac pacemakers. IEEE Trans Biomed Eng 1971; 18:317-323.
19. Nathan DA, Center S, Wu C-Y, et al. An implantable synchronous pacemaker for the long term correction of complete heart block. Circulation 1963; 27:682-685.
20. Funke HD. Optimized sequential pacing of atria and ventricles: A new concept in treatment of bradycardiac dysrhythmias. [in German] Herz Kreislauf 1978; 10:479-483.
21. Aubert AE, Ector H. New lead technology for the 21st century. In GE Antonioli (ed.): Pacemaker Leads. Bologna, Italy, Monduzzi, 1997, pp. 17-24.
22. Furman S. Pacemaker programmability. PACE 1978; 1:161-162.
23. Chardack WM, Gage AA, Federico AJ, et al. Five years's clinical experience with an implantable pacemaker: An appraisal. Surgery 1965; 58:915-922.
24. Kantrowitz A, Cohen R, Raillard H, et al. The treatment of complete heart block with an implanted controllable pacemaker. Surg Gynecol Obstet 1962; 115:415-420.
25. Parsonnet V, Cuddy TE, Escher DJW, et al. A pacemaker capable of external non-invasive programming. Trans Am Soc Artif Intern Organs 1973; 19:224-228.
26. Samet P, Bernstein WH, Nathan DA, et al. Atrial contribution to cardiac output in complete heart block. Am J Cardiol 1965; 16:1-10.
27. Benchimol A, Duenas A, Liggett MS, et al. Contribution of atrial systole to the cardiac function at a fixed and at a variable ventricular rate. Am J Cardiol 1965; 16:11-21.
28. Karlof I. Haemodynamic effect of atrial triggered versus fixed rate pacing at rest and during exercise in complete heart block. Acta Med Scand 1975; 197:195-206.
29. Humen DP, Kostuk WJ, Klein GJ. Activity-sensing rate-responsive pacing: Improvement in myocardial performance with exercise. PACE 1985; 8:52-59.
30. Alt E, Heinz M, Hirgstetter C, et al. Control of pacemaker rate by impedance-based respiratory minute ventilation. Chest 1987; 92:247-252.
31. Rickards AF, Donaldson RM, Thalen HJ. The use of QT interval to determine pacing rate: Early clinical experience. PACE 1983; 6:346-356.
32. Mahaux V, Waleffe A, Kulbertus HE. Clinical experience with a new activity sensing rate modulated pacemaker using autoprogrammability. PACE 1990; 13:811-820.
33. Parsonnet V, Furman S, Smyth NPD. Implantable cardiac pacemakers. Status report and resource guideline: Pacemaker study grouop. Circulation 1974; 50:A-21-A-35.
34. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code of antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. PACE 2002; 25:260-264.
35. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106:2145.
36. Andersen HR, Nielsen JC, Thomsen PE, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350:1210.
37. Lamas GA, Orav EJ, Stambler BS, et al. Pacemaker selection in the elderly investigators: Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338:1097.
38. Connolly SJ, Kerr CR, Gent M, et al. Canadian Trial of Physiologic Pacing Investigators: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000; 342:1385.
39. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854.
40. Toff WD, Skehan JD, De Bono DP, et al. The United Kingdom Pacing and Cardiovascular Events (UKPACE) trial: United Kingdom Pacing and Cardiovascular Events. Heart 1997; 78:221.
41. Connolly SJ, Sheldon R, Roberts RS, et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33:16-20.
42. Sutton R, Brognole M, Menozzi C, et al. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: Pacemaker versus no therapy: A multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000; 102:294-299.
43. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagalsyncope: Second vasovagal pacemaker study (VPS II): A randomized trial. JAMA 2003; 289:2272-2275.
44. Fananapazir L, Epstein ND, Curiel RV, et al. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90:2731-2742.
45. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hyeprtrophic cardiomyopathy: A randomized, double-blind crossover trial. J Am Coll Cardiol 1997; 29:435-441.
46. Kappenberger L, Linde C, Daubert C, et al., and the PIC Study Group: Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. Eur Heart J 1997; 18:1249-1256.
47. Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obsgtructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999; 99:2927-2933.
48. Maron BJ, Shen WK, Link MS, et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342:422-424.
49. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17:1974-1979.
50. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation 2003; 108:2596-2603.
51. Auricchio A, Stellbrink C, Sack S. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39:2026-2033.
52. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344:873-880.
53. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346:1902-1905.
54. Young JB, Abraham JS, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289:2685-2694.
55. Thackray S, Coletta A, Jones P, et al. Clinical trials update: High-lights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001; 3:491-494.
56. Bristow MR, Feldman AM, Saxon LA. Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators. J Card Fail 2000; 6:276-285.
57. Cleland JG, Daubert JC, Erdmann E, et al. The CARE-HF study (Cardiac Resynchronisation in Heart Failure study): Rationale, design and end-points. Eur J Heart Fail 2001; 3:481-489.
58. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003; 89:54-60.
59. Saksena S, Prakash A, Ziegler P, et al. Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40:1140-1150.
60. Carlson MD, Messenger J, Beau S, et al.A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT) J Am Coll Cardiol 2003; 42:627-633.
61. Lee MA, Weachter R, Pollak S, et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency results of a randomized trial in patients with bradycardiac and atrial tachyarrhythmias. J Am Coll Cardiol 2003; 41:1926-1932.